Earnings Call · Q4 FY2022·2023-03-08

Q4 22EPS -27.27%·Rev n/aQ3 22EPS +9.66%·Rev n/aQ2 22EPS -26.91%·Rev n/aQ4 21EPS -69.72%·Rev n/a⚠ consensus missing

Biofrontera Inc. BFRI

Unidentified Company Representative — Company Representative

Erica Monaco — Chief Executive Officer

Fred Leffler — Chief Financial Officer

+12.2%1d on move date+12.3% vs SPY3d+8.9%5d+11.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BFRI calls or request research access.

More BFRI calls Browse calls Request research access